Beyond targeting malignant B cells

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)657-658
Number of pages2
JournalThe Lancet Oncology
Volume13
Issue number7
DOIs
StatePublished - Jul 2012

Fingerprint

Antineoplastic Combined Chemotherapy Protocols
Mantle-Cell Lymphoma
B-Lymphocytes

ASJC Scopus subject areas

  • Oncology

Cite this

Beyond targeting malignant B cells. / Ansell, Stephen Maxted.

In: The Lancet Oncology, Vol. 13, No. 7, 07.2012, p. 657-658.

Research output: Contribution to journalArticle

@article{25e9e03e8714482684c878eb75a09333,
title = "Beyond targeting malignant B cells",
author = "Ansell, {Stephen Maxted}",
year = "2012",
month = "7",
doi = "10.1016/S1470-2045(12)70223-1",
language = "English (US)",
volume = "13",
pages = "657--658",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "7",

}

TY - JOUR

T1 - Beyond targeting malignant B cells

AU - Ansell, Stephen Maxted

PY - 2012/7

Y1 - 2012/7

UR - http://www.scopus.com/inward/record.url?scp=84863095840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863095840&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(12)70223-1

DO - 10.1016/S1470-2045(12)70223-1

M3 - Article

C2 - 22677153

AN - SCOPUS:84863095840

VL - 13

SP - 657

EP - 658

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 7

ER -